(Q36740036)

16 August 2017

1 reference

title

Antibiotics and antifungals in neonatal intensive care units: a review (English)

1 reference

16 August 2017

0 references

1 reference

Fanos V

1

1 reference

16 August 2017

Cuzzolin L

series ordinal

2

1 reference

16 August 2017

Atzei A

series ordinal

3

1 reference

16 August 2017

Testa M

series ordinal

4

1 reference

16 August 2017

language of work or name

1 reference

1 February 2007

1 reference

16 August 2017

Journal of Chemotherapy

1 reference

16 August 2017

19

1 reference

16 August 2017

1

1 reference

16 August 2017

5-20

1 reference

Strategic use of antibiotics in the neonatal intensive care unit

16 August 2017

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2007.19.1.5

New dosing strategies for antibacterial agents in the neonate

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2007.19.1.5

Infection in the preterm infant

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2007.19.1.5

Early-onset sepsis in very low birth weight neonates: a report from the National Institute of Child Health and Human Development Neonatal Research Network

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2007.19.1.5

Late-onset sepsis in very low birth weight neonates: the experience of the NICHD Neonatal Research Network

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2007.19.1.5

Antibacterial-induced nephrotoxicity in the newborn

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2007.19.1.5

Nosocomial bacterial infections in very low birth weight infants

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2007.19.1.5

Risk factors for candidemia in Neonatal Intensive Care Unit patients. The National Epidemiology of Mycosis Survey study group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2007.19.1.5

Strategies for prevention of neonatal invasive candidiasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2007.19.1.5

Antibiotic use in the neonatal unit

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2007.19.1.5

Beta-lactam antibiotics: their role in the management of infections in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2007.19.1.5

Staphylococcus epidermidis isolation and antibiotic resistance in a neonatal intensive care unit.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2007.19.1.5

Use of Percutaneous Silastic Central Venous Catheters in Neonates and the Management of Infectious Complications

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2007.19.1.5

Clinical pharmacokinetics of antibacterial drugs in neonates

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2007.19.1.5

Safety evaluation of piperacillin/tazobactam in very low birth weight infants

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2007.19.1.5

Adverse drug reactions in neonates

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2007.19.1.5

Modern beta-lactam antibiotics

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2007.19.1.5

Outbreak of extended spectrum beta lactamase producing Klebsiella pneumoniae in a neonatal unit

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2007.19.1.5

Outbreak of SHV-5 beta-lactamase-producing Klebsiella pneumoniae in a neonatal-pediatric intensive care unit in Spain

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2007.19.1.5

Nosocomial spread of ceftazidime-resistant Klebsiella pneumoniae strains producing a novel class a beta-lactamase, GES-3, in a neonatal intensive care unit in Japan

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2007.19.1.5

Attributable costs and length of stay of an extended-spectrum beta-lactamase-producing Klebsiella pneumoniae outbreak in a neonatal intensive care unit

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2007.19.1.5

A comparison of ceftazidime and aminoglycoside based regimens as empirical treatment in 1316 cases of suspected sepsis in the newborn. European Society for Paediatric Infectious Diseases--Neonatal Sepsis Study Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2007.19.1.5

Comparative toxicities of third-generation cephalosporins

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2007.19.1.5

Outbreak of cephalosporin resistant Enterobacter cloacae infection in a neonatal intensive care unit

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2007.19.1.5

21 January 2018

Cephalosporin allergy

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2007.19.1.5

Safety of parenteral third-generation cephalosporins

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2007.19.1.5

Fatal hemolysis caused by ceftriaxone.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2007.19.1.5

Fatal hemolysis induced by ceftriaxone in a child with sickle cell anemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2007.19.1.5

Antimicrobial agents and Clostridium difficile in acute enteric disease: epidemiological data from Sweden, 1980-1982.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2007.19.1.5

Mechanisms of cephalosporin nephrotoxicity: a comparison of cephaloridine and cephaloglycin

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2007.19.1.5

The cephalosporin compounds in severe neonatal infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2007.19.1.5

Nephrotoxicity of beta-lactam antibiotics: mechanisms and strategies for prevention

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2007.19.1.5

In vitro displacement of bilirubin by antibiotics and 2-hydroxybenzoylglycine in newborns

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2007.19.1.5

Pharmacokinetics and renal tolerance of aztreonam in premature infants

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2007.19.1.5

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2007.19.1.5

Pharmacokinetics of imipenem-cilastatin in neonates

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2007.19.1.5

Single-dose pharmacokinetics of imipenem-cilastatin in neonates

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2007.19.1.5

Detection of antimicrobial resistance and extended-spectrum beta-lactamase production in Klebsiella pneumoniae strains from infected neonates

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2007.19.1.5

Use of meropenem in the treatment of serious infections in children: review of the current literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2007.19.1.5

Meropenem: a new, extremely broad spectrum beta-lactam antibiotic for serious infections in pediatrics

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2007.19.1.5

Newborns and gentamicin--how much and how often?

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2007.19.1.5

Predictability of peak serum gentamicin concentration with dosage based on body surface area

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2007.19.1.5

Tobramycin population pharmacokinetics in neonates.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2007.19.1.5

Newborn hearing screening: tobramycin and vancomycin are not risk factors for hearing loss

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2007.19.1.5

Clinical response to aminoglycoside therapy: importance of the ratio of peak concentration to minimal inhibitory concentration

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2007.19.1.5

Extended-interval aminoglycoside administration for children: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2007.19.1.5

Once daily dosing of gentamicin in infants and children

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2007.19.1.5

A biochemical basis for the inherited susceptibility to aminoglycoside ototoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2007.19.1.5

Gentamicin usage in newborns: an audit

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2007.19.1.5

Extended interval dosing of gentamicin in preterm infants

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2007.19.1.5

Once-daily gentamicin dosing for the preterm and term newborn: proposal for a simple regimen that achieves target levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2007.19.1.5

The effect of postnatal age on gentamicin pharmacokinetics in neonates

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2007.19.1.5

Vancomycin: pharmacokinetics and administration regimens in neonates

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2007.19.1.5

A review of teicoplanin in the treatment of serious neonatal infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2007.19.1.5

Pharmacokinetics and dose requirements of vancomycin in neonates

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2007.19.1.5

Use of teicoplanin in preterm neonates with staphylococcal late-onset neonatal sepsis

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2007.19.1.5

Vancomycin ototoxicity and nephrotoxicity. A review

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2007.19.1.5

Selective use of vancomycin to prevent coagulase-negative staphylococcal nosocomial bacteremia in high risk very low birth weight infants

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2007.19.1.5

Chloramphenicol toxicity in neonates: its incidence and prevention

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2007.19.1.5

Chloramphenicol in paediatrics: current prescribing practice and the need to monitor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2007.19.1.5

Intravenous trimethoprim-sulfamethoxazole in the treatment of serious infections in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2007.19.1.5

Pharmacokinetics of anti-infective agents in paediatric patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2007.19.1.5

Pharmacology of trimethoprim-sulfamethoxazole in newborn infants

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2007.19.1.5

Role of erythromycin for treatment of incipient chronic lung disease in preterm infants colonised with Ureaplasma urealyticum

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2007.19.1.5

Erythromycin for the prevention of chronic lung disease in intubated preterm infants at risk for, or colonized or infected with Ureaplasma urealyticum

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2007.19.1.5

Erythromycin fails to improve feeding outcome in feeding-intolerant preterm infants.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2007.19.1.5

Erythromycin as a prokinetic agent in preterm infants

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2007.19.1.5

Influence of erythromycin on establishment of feeding in preterm infants: observations from a randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2007.19.1.5

Pharmacokinetics of erythromycin ethylsuccinate and estolate in infants under 4 months of age.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2007.19.1.5

Maternal and infant use of erythromycin and other macrolide antibiotics as risk factors for infantile hypertrophic pyloric stenosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2007.19.1.5

Pharmacokinetic interactions of the macrolide antibiotics

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2007.19.1.5

Surveillance for transmission and antibiotic adverse events among neonates and adults exposed to a healthcare worker with pertussis

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2007.19.1.5

Infantile hypertrophic pyloric stenosis after pertussis prophylaxis with erythromcyin: a case review and cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2007.19.1.5

Use of intravenous rifampin in neonates with persistent staphylococcal bacteremia

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2007.19.1.5

Growth and development in preterm infants receiving fluoroquinolones.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2007.19.1.5

Use of ciprofloxacin in neonatal sepsis: lack of adverse effects up to one year

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2007.19.1.5

Activity of linezolid against anaerobic bacteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2007.19.1.5

Activities of linezolid against rapidly growing mycobacteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2007.19.1.5

In vitro activities of linezolid combined with other antimicrobial agents against Staphylococci, Enterococci, Pneumococci, and selected gram-negative organisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2007.19.1.5

Linezolid pharmacokinetics in pediatric patients: an overview

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2007.19.1.5

Hematologic effects of antimicrobials: focus on the oxazolidinone linezolid

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2007.19.1.5

Thrombocytopenia secondary to linezolid administration: what is the risk?

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2007.19.1.5

Antifungals in systemic neonatal candidiasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2007.19.1.5

Liposomal amphotericin B (AmBisome) in the treatment of neonatal candidiasis in very low birth weight infants

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2007.19.1.5

Amphotericin B nephrotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2007.19.1.5

Effects of fluid and electrolyte management on amphotericin B-induced nephrotoxicity among extremely low birth weight infants

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2007.19.1.5

Overview of the lipid formulations of amphotericin B.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2007.19.1.5

Pharmacokinetics of fluconazole in very low birth weight infants during the first two weeks of life

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2007.19.1.5

Emergence of fluconazole resistance in a Candida parapsilosis strain that caused infections in a neonatal intensive care unit

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2007.19.1.5

Intravenous voriconazole therapy in a preterm infant

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2007.19.1.5

Antibiotics or surgery for vesicoureteric reflux in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2007.19.1.5

Antibiotic prophylaxis in children with relapsing urinary tract infections: review

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2007.19.1.5

21 January 2018

Identifiers

DOI

10.1179/JOC.2007.19.1.5

1 reference

16 August 2017

1 reference